Published in Atherosclerosis on October 24, 2007
Equol: pharmacokinetics and biological actions. J Nutr (2010) 1.25
Therapeutic modification of arterial stiffness: An update and comprehensive review. World J Cardiol (2015) 0.85
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature. Nutrients (2016) 0.85
Estrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cells. PLoS One (2013) 0.79
Impact of perinatal exposure to equol enantiomers on reproductive development in rodents. Reprod Toxicol (2011) 0.78
The Effect of Eqoul, a Metabolite of Isoflavone, on Endothelial Cell-independent Vasodilatation of Human Uterine Artery In Vitro. J Bone Metab (2015) 0.77
Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Am J Clin Nutr (2016) 0.76
The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials. J Nutr Sci (2016) 0.75
Research protocol: effect of natural S-equol on blood pressure and vascular function- a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension. BMC Complement Altern Med (2016) 0.75
Soy-tibolone combination - effect on lipids in postmenopausal monkeys and women. Maturitas (2008) 0.75
Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med (2003) 3.55
Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA (2005) 3.01
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care (2011) 2.20
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia (2015) 2.05
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens (2006) 1.62
Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol (2006) 1.61
Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60
Self-reported smoking habits and serum cotinine levels in women with placental abruption. Acta Obstet Gynecol Scand (2010) 1.58
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes (2009) 1.55
Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci (2009) 1.53
Birth weight is inversely correlated to adult systolic blood pressure and pulse pressure in type 1 diabetes. Hypertension (2004) 1.51
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Benefits and risks of long-term low-dose oral continuous combined hormone therapy. Maturitas (2006) 1.50
Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology (2006) 1.50
Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res (2002) 1.49
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
Destruction of primordial ovarian follicles in adult cynomolgus macaques after exposure to 4-vinylcyclohexene diepoxide: a nonhuman primate model of the menopausal transition. Fertil Steril (2006) 1.46
Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis. Menopause (2012) 1.42
Male fetal sex is associated with earlier onset of placental abruption. Acta Obstet Gynecol Scand (2010) 1.42
Abnormal cervical cytology is associated with increased nitric oxide release in the uterine cervix. Acta Obstet Gynecol Scand (2009) 1.40
The association between plasma 25-hydroxyvitamin D3 concentrations, C-reactive protein levels, and coronary artery atherosclerosis in postmenopausal monkeys. Menopause (2012) 1.40
Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes (2010) 1.39
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes (2012) 1.36
High-throughput pedigree drawing. Eur J Hum Genet (2005) 1.36
Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care (2005) 1.35
Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes (2003) 1.29
The unique value of primate models in translational research. Nonhuman primate models of women's health: introduction and overview. Am J Primatol (2009) 1.28
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care (2012) 1.26
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ (2011) 1.26
Heritability of proliferative diabetic retinopathy. Diabetes (2008) 1.25
The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol (2008) 1.22
Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci (2011) 1.22
Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet (2002) 1.21
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes (2008) 1.20
Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care (2009) 1.18
Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care (2003) 1.17
Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis. Atherosclerosis (2003) 1.17
Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol (2009) 1.16
Incidence of type 1 diabetes in Finland. JAMA (2013) 1.15
Altered age-related blood pressure pattern in type 1 diabetes. Circulation (2004) 1.15
Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr (2006) 1.15
Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr (2003) 1.14
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Social stress, visceral obesity, and coronary artery atherosclerosis in female primates. Obesity (Silver Spring) (2009) 1.11
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma. Clin Cancer Res (2004) 1.11
Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant (2009) 1.10
Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol (2009) 1.09
Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab (2004) 1.08
A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes (2007) 1.08
Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol (2007) 1.07
Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care (2009) 1.06
Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand (2006) 1.05
Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA (2006) 1.04
Plasma lipid-dependent and -independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmenopausal atherosclerosis burden. Menopause (2008) 1.04
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care (2008) 1.04
A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun (2008) 1.04
Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy. Diabetes Care (2009) 1.02
Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab (2005) 1.02
Depressive behavior and coronary artery atherogenesis in adult female cynomolgus monkeys. Psychosom Med (2008) 1.02
Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur J Hum Genet (2005) 1.01
Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens (2012) 1.01
Association between vasomotor hot flashes and heart rate variability in recently postmenopausal women. Menopause (2010) 1.00
Physical activity and diabetes complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study. Diabetes Care (2007) 0.98
Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus. Am J Hum Genet (2008) 0.98
Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Ann Med (2008) 0.98
Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care (2013) 0.98
Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J Am Soc Nephrol (2013) 0.98
Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study. Hypertension (2005) 0.97
Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol (2009) 0.96
G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes. Diabetes (2008) 0.96
The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes (2003) 0.96
European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy. Nephrol Dial Transplant (2007) 0.96
Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial. Menopause (2003) 0.95
Pulse wave reflection in currently and previously preeclamptic women. Hypertens Pregnancy (2005) 0.95
Effects of soybean glyceollins and estradiol in postmenopausal female monkeys. Nutr Cancer (2006) 0.95
A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol (2003) 0.95
Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab (2004) 0.95
Effect of hot flushes on vascular function: a randomized controlled trial. Obstet Gynecol (2009) 0.94
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment. Vasc Health Risk Manag (2013) 0.94
Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care (2010) 0.94
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med (2009) 0.94
Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women. Menopause (2005) 0.93